Loading...
Please wait, while we are loading the content...
Similar Documents
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
| Content Provider | Scilit |
|---|---|
| Author | Rubenstein, James L. Geng, Huimin Fraser, Eleanor J. Formaker, Paul Chen, Lingjing Sharma, Jigyasa Killea, Phoebe Choi, Kaylee Ventura, Jenny Kurhanewicz, John Lowell, Clifford Hwang, Jimmy Treseler, Patrick Sneed, Penny K. Li, Jing Wang, Xiaomin Chen, Nianhang Gangoiti, Jon Munster, Pamela N. Damato, Bertil |
| Copyright Year | 2018 |
| Description | Key Points Lenalidomide penetrates ventricular CSF and is active as monotherapy in relapsed CNS lymphomas. Maintenance lenalidomide is feasible and may potentiate response duration after salvage in relapsed PCNSL and delay WBRT. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039666/pdf |
| Ending Page | 1607 |
| Page Count | 13 |
| Starting Page | 1595 |
| DOI | 10.1182/bloodadvances.2017014845 |
| Journal | Blood advances |
| Issue Number | 13 |
| Volume Number | 2 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2018-07-10 |
| Access Restriction | Open |
| Subject Keyword | Hematology Relapsed Salvage Delay Csf Monotherapy Duration Ventricular Pcnsl Penetrates Lenalidomide/rituximab Journal: Blood advances (Vol- 122, Issue- 13) |
| Content Type | Text |
| Resource Type | Article |